<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02817776</url>
  </required_header>
  <id_info>
    <org_study_id>STSF-159</org_study_id>
    <nct_id>NCT02817776</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)</brief_title>
  <acronym>PRECEPT</acronym>
  <official_title>Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF (STSF) Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biosense Webster, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biosense Webster, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, non-randomized clinical evaluation utilizing the&#xD;
      THERMOCOOL SMARTTOUCH® SF catheter compared to a predetermined performance goal.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL&#xD;
      SMARTTOUCH® SF catheter in the treatment of drug refractory symptomatic persistent atrial&#xD;
      fibrillation (PsAF) following standard electrophysiology mapping and radio frequency (RF)&#xD;
      ablation procedures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">June 5, 2019</completion_date>
  <primary_completion_date type="Actual">June 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety Endpoint - Percentage of Participants With Any PAE Within 7 Days</measure>
    <time_frame>7 days (except as noted in analysis population description)</time_frame>
    <description>The primary safety endpoint is the incidence of any early onset (within 7 days of the initial and repeat AF ablation procedure) Primary Adverse Events (AE), which are listed below:&#xD;
Death&#xD;
Atrio-esophageal fistula*&#xD;
Cardiac Tamponade**+/Perforation+&#xD;
Myocardial infarction (MI)&#xD;
Stroke / Cerebrovascular accident (CVA) †, ††&#xD;
Thromboembolism&#xD;
Transient Ischemic Attack&#xD;
Diaphragmatic paralysis&#xD;
Pneumothorax&#xD;
Heart block&#xD;
PV stenosis*&#xD;
Pulmonary edema (Respiratory Insufficiency)&#xD;
Pericarditis&#xD;
Major Vascular access complication / bleeding</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness: Freedom From Documented Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes Through 15-month Follow-up</measure>
    <time_frame>15-month follow-up</time_frame>
    <description>The primary effectiveness endpoint for this study will be freedom from documented atrial fibrillation (AF), atrial tachycardia (AT), or atrial flutter (AFL) episodes through 15-month follow-up (post 3-Month Medication Adjustment Period followed by a 3-Month Therapy Consolidation period (Day 181-450)) and freedom from the following failure modes:&#xD;
Acute Procedural Failure&#xD;
Non-Study Catheter Failure&#xD;
Repeat Ablation Failure&#xD;
AAD Failure&#xD;
Surgical Failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute Procedural Success</measure>
    <time_frame>Immediate post-procedure</time_frame>
    <description>Acute procedural success is defined as confirmation of entrance block in all pulmonary veins.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>15-Month Single Procedure Success</measure>
    <time_frame>15-Month</time_frame>
    <description>The 15-month single procedure success is defined as freedom from documented AF/AFL/AT recurrence (episodes &gt; 30 secs) during the Evaluation Period after a single ablation procedure. Any repeat ablation procedure during the Evaluation Period will be deemed effectiveness failure for this analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early Onset Serious Adverse Event (SAE)</measure>
    <time_frame>7 days</time_frame>
    <description>Occurrence of Early Onset (within 7 days of initial ablation) Serious Adverse Event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-Procedural Serious Adverse Event (SAE)</measure>
    <time_frame>&gt;7 to 30 days</time_frame>
    <description>Peri-Procedural (&gt;7 to 30 days) Serious Adverse Event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Onset Serious Adverse Event (SAE)</measure>
    <time_frame>&gt;30 days up to 15 months</time_frame>
    <description>Occurrence of Late Onset (&gt;30 days) Serious Adverse Event</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">381</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THERMOCOOL SMARTTOUCH® SF catheter</intervention_name>
    <description>Radiofrequency Ablation</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Candidates for this study must meet ALL of the following criteria:&#xD;
&#xD;
          1. Documented symptomatic persistent AF, which is defined as continuous AF sustains&#xD;
             beyond 7 days and less than 1 year and is documented by the following:.&#xD;
&#xD;
               1. Physician's note indicating continuous AF ≥ 7 days but no more than 1 year; AND&#xD;
&#xD;
               2. Two electrocardiograms (from any forms of rhythm monitoring) showing continuous&#xD;
                  AF, with electrocardiogram taken at least 7 days apart OR&#xD;
&#xD;
               3. 24-hour Holter within 90 days of the ablation procedure showing continuous AF&#xD;
&#xD;
          2. Failed at least one antiarrhythmic drug (AAD) (class I or III) as evidenced by&#xD;
             recurrent symptomatic AF, or intolerable to the AAD.&#xD;
&#xD;
          3. Age 18 years or older.&#xD;
&#xD;
          4. Signed Patient Informed Consent Form (ICF).&#xD;
&#xD;
          5. Able and willing to comply with all pre-, post-, and follow-up testing and&#xD;
             requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Candidates for this study will be EXCLUDED from the study if ANY of the following&#xD;
        conditions apply:&#xD;
&#xD;
          1. Continuous AF &gt; 12 months (1-Year) (Longstanding Persistent AF)&#xD;
&#xD;
          2. Previous surgical or catheter ablation for atrial fibrillation&#xD;
&#xD;
          3. Any cardiac surgery within the past 2 months (60 days) (includes percutaneous coronary&#xD;
             intervention (PCI))&#xD;
&#xD;
          4. Coronary Artery Bypass Graft (CABG) surgery within the past 6 months (180 days)&#xD;
&#xD;
          5. Valvular cardiac surgical/percutaneous procedure (i.e., ventriculotomy, atriotomy, and&#xD;
             valve repair or replacement and presence of a prosthetic valve)&#xD;
&#xD;
          6. Any carotid stenting or endarterectomy&#xD;
&#xD;
          7. Documented left atrial (LA) thrombus on imaging&#xD;
&#xD;
          8. LA size &gt; 50 mm (parasternal long axis view)&#xD;
&#xD;
          9. Left ventricular ejection fraction (LVEF) &lt; 40%&#xD;
&#xD;
         10. Contraindication to anticoagulation (heparin or warfarin)&#xD;
&#xD;
         11. History of blood clotting or bleeding abnormalities&#xD;
&#xD;
         12. MI within the past 2 months (60 days)&#xD;
&#xD;
         13. Documented thromboembolic event (including Transient Ischemic Attack (TIA) within the&#xD;
             past 12 months (365 days)&#xD;
&#xD;
         14. Rheumatic Heart Disease&#xD;
&#xD;
         15. Uncontrolled heart failure or New York Heart Association (NYHA) function class III or&#xD;
             IV&#xD;
&#xD;
         16. Severe mitral regurgitation (Regurgitant volume ≥ 60 mL/beat, Regurgitant fraction ≥&#xD;
             50%, and/or Effective regurgitant orifice area ≥ 0.40cm2)&#xD;
&#xD;
         17. Awaiting cardiac transplantation or other cardiac surgery within the next 12 months&#xD;
             (365 days)&#xD;
&#xD;
         18. Unstable angina&#xD;
&#xD;
         19. Acute illness or active systemic infection or sepsis&#xD;
&#xD;
         20. AF secondary to electrolyte imbalance, thyroid disease, or reversible or non-cardiac&#xD;
             cause.&#xD;
&#xD;
         21. Diagnosed atrial myxoma.&#xD;
&#xD;
         22. Presence of implanted implantable cardioverter defibrillator (ICD) /cardiac&#xD;
             resynchronization therapy defibrillator (CRT-D).&#xD;
&#xD;
         23. Significant pulmonary disease, (e.g., restrictive pulmonary disease, constrictive or&#xD;
             chronic obstructive pulmonary disease) or any other disease or malfunction of the&#xD;
             lungs or respiratory system that produces chronic symptoms.&#xD;
&#xD;
         24. Gastroesophageal Reflux Disease (GERD; active requiring significant intervention not&#xD;
             including over-the-counter (OTC) medication)&#xD;
&#xD;
         25. Significant congenital anomaly or medical problem that in the opinion of the&#xD;
             investigator would preclude enrollment in this study.&#xD;
&#xD;
         26. Women who are pregnant (as evidenced by pregnancy test if pre-menopausal)&#xD;
&#xD;
         27. Enrollment in an investigational study evaluating another device, biologic, or drug.&#xD;
&#xD;
         28. Presence of intramural thrombus, tumor or other abnormality that precludes vascular&#xD;
             access, or manipulation of the catheter.&#xD;
&#xD;
         29. Presence of any other condition that precludes appropriate vascular access.&#xD;
&#xD;
         30. Life expectancy less than 12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Natale, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Cardiac Arrhythmia Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis Marchlinski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruce Koplan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walid Saliba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tristram Banhson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott Pollak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AdventHealth</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugh Calkins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moussa Mansour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas Packer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Srinivas Dukkipati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larry Chinitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saumil Oza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Vincent's</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anshul Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University Saint Joseph's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Fishel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>JFK Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Maddox, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Mazur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Melby, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allina Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Presbyterian Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Ellenbogen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chad Brodt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurent Macle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Heart</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philip Gentlesk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sentara Heart Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James B Deville, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charles Athill, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Diego Cardiac Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig Delaughter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Health Heart &amp; Vascular</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marwan Bahu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phoenix Cardiovascular Research Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Osorio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affinity Cardiovascular Specialists (Alabama Cardiovascular Group)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Deyell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Paul</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Affinity Cardiovascular Specialists (Alabama Cardiovascular Group)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phoenix Cardiovascular Research Group</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Diego Cardiac Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>92201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Vincent's Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory Saint Joseph's Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Foundation</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Hospital</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital - Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Heart &amp; Vascular Hospital</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Heart Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23284</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>BC V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quabec</state>
        <zip>QC H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <results_first_submitted>October 30, 2020</results_first_submitted>
  <results_first_submitted_qc>December 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 12, 2021</results_first_posted>
  <disposition_first_submitted>May 28, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>July 10, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">July 14, 2020</disposition_first_posted>
  <last_update_submitted>December 18, 2020</last_update_submitted>
  <last_update_submitted_qc>December 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Interventional</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>Persistent Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 31, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT02817776/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT02817776/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Total of 367 subjects were proposed in the protocol to be enrolled for this study. The enrollment had been completed and closed after reaching a total of 381 enrolled subjects.&#xD;
The last subject was enrolled on February 6th, 2018.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Treatment Group</title>
          <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="381">33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="293"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="88"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Excluded</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment Group</title>
          <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="381"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.6" spread="8.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="357"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="349"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Safety Endpoint - Percentage of Participants With Any PAE Within 7 Days</title>
        <description>The primary safety endpoint is the incidence of any early onset (within 7 days of the initial and repeat AF ablation procedure) Primary Adverse Events (AE), which are listed below:&#xD;
Death&#xD;
Atrio-esophageal fistula*&#xD;
Cardiac Tamponade**+/Perforation+&#xD;
Myocardial infarction (MI)&#xD;
Stroke / Cerebrovascular accident (CVA) †, ††&#xD;
Thromboembolism&#xD;
Transient Ischemic Attack&#xD;
Diaphragmatic paralysis&#xD;
Pneumothorax&#xD;
Heart block&#xD;
PV stenosis*&#xD;
Pulmonary edema (Respiratory Insufficiency)&#xD;
Pericarditis&#xD;
Major Vascular access complication / bleeding</description>
        <time_frame>7 days (except as noted in analysis population description)</time_frame>
        <population>The safety population was used as the primary analysis population. Subjects with missing 3-month follow-up were excluded from the primary analysis unless the subjects experienced a Primary AE prior to the 3-month visit post-procedure. PV stenosis and AE fistula that occurred &gt; 1 week and cardiac tamponade/perforation that occurred up to 30 days post ablation were also deemed Primary AEs.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Safety Endpoint - Percentage of Participants With Any PAE Within 7 Days</title>
          <description>The primary safety endpoint is the incidence of any early onset (within 7 days of the initial and repeat AF ablation procedure) Primary Adverse Events (AE), which are listed below:&#xD;
Death&#xD;
Atrio-esophageal fistula*&#xD;
Cardiac Tamponade**+/Perforation+&#xD;
Myocardial infarction (MI)&#xD;
Stroke / Cerebrovascular accident (CVA) †, ††&#xD;
Thromboembolism&#xD;
Transient Ischemic Attack&#xD;
Diaphragmatic paralysis&#xD;
Pneumothorax&#xD;
Heart block&#xD;
PV stenosis*&#xD;
Pulmonary edema (Respiratory Insufficiency)&#xD;
Pericarditis&#xD;
Major Vascular access complication / bleeding</description>
          <population>The safety population was used as the primary analysis population. Subjects with missing 3-month follow-up were excluded from the primary analysis unless the subjects experienced a Primary AE prior to the 3-month visit post-procedure. PV stenosis and AE fistula that occurred &gt; 1 week and cardiac tamponade/perforation that occurred up to 30 days post ablation were also deemed Primary AEs.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="344"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness: Freedom From Documented Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes Through 15-month Follow-up</title>
        <description>The primary effectiveness endpoint for this study will be freedom from documented atrial fibrillation (AF), atrial tachycardia (AT), or atrial flutter (AFL) episodes through 15-month follow-up (post 3-Month Medication Adjustment Period followed by a 3-Month Therapy Consolidation period (Day 181-450)) and freedom from the following failure modes:&#xD;
Acute Procedural Failure&#xD;
Non-Study Catheter Failure&#xD;
Repeat Ablation Failure&#xD;
AAD Failure&#xD;
Surgical Failure</description>
        <time_frame>15-month follow-up</time_frame>
        <population>The PP population was used as the primary analysis population. Subjects who did not complete the 15-month follow-up were considered missing and were excluded from the primary analysis unless the subjects experienced effectiveness failure prior to exiting the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness: Freedom From Documented Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes Through 15-month Follow-up</title>
          <description>The primary effectiveness endpoint for this study will be freedom from documented atrial fibrillation (AF), atrial tachycardia (AT), or atrial flutter (AFL) episodes through 15-month follow-up (post 3-Month Medication Adjustment Period followed by a 3-Month Therapy Consolidation period (Day 181-450)) and freedom from the following failure modes:&#xD;
Acute Procedural Failure&#xD;
Non-Study Catheter Failure&#xD;
Repeat Ablation Failure&#xD;
AAD Failure&#xD;
Surgical Failure</description>
          <population>The PP population was used as the primary analysis population. Subjects who did not complete the 15-month follow-up were considered missing and were excluded from the primary analysis unless the subjects experienced effectiveness failure prior to exiting the study.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="297"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acute Procedural Success</title>
        <description>Acute procedural success is defined as confirmation of entrance block in all pulmonary veins.</description>
        <time_frame>Immediate post-procedure</time_frame>
        <population>Per Protocol Population</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Procedural Success</title>
          <description>Acute procedural success is defined as confirmation of entrance block in all pulmonary veins.</description>
          <population>Per Protocol Population</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="333"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>15-Month Single Procedure Success</title>
        <description>The 15-month single procedure success is defined as freedom from documented AF/AFL/AT recurrence (episodes &gt; 30 secs) during the Evaluation Period after a single ablation procedure. Any repeat ablation procedure during the Evaluation Period will be deemed effectiveness failure for this analysis.</description>
        <time_frame>15-Month</time_frame>
        <population>Per Protocol Population, n=333, minus 3 acute procedural failures and 36 missing outcomes not included in primary effectiveness endpoint calculation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>15-Month Single Procedure Success</title>
          <description>The 15-month single procedure success is defined as freedom from documented AF/AFL/AT recurrence (episodes &gt; 30 secs) during the Evaluation Period after a single ablation procedure. Any repeat ablation procedure during the Evaluation Period will be deemed effectiveness failure for this analysis.</description>
          <population>Per Protocol Population, n=333, minus 3 acute procedural failures and 36 missing outcomes not included in primary effectiveness endpoint calculation.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="294"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Early Onset Serious Adverse Event (SAE)</title>
        <description>Occurrence of Early Onset (within 7 days of initial ablation) Serious Adverse Event</description>
        <time_frame>7 days</time_frame>
        <population>Safety Population (number of subjects with study catheter inserted) was the analysis population for secondary safety endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>Early Onset Serious Adverse Event (SAE)</title>
          <description>Occurrence of Early Onset (within 7 days of initial ablation) Serious Adverse Event</description>
          <population>Safety Population (number of subjects with study catheter inserted) was the analysis population for secondary safety endpoints.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peri-Procedural Serious Adverse Event (SAE)</title>
        <description>Peri-Procedural (&gt;7 to 30 days) Serious Adverse Event</description>
        <time_frame>&gt;7 to 30 days</time_frame>
        <population>Safety Population (number of subjects with study catheter inserted)</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>Peri-Procedural Serious Adverse Event (SAE)</title>
          <description>Peri-Procedural (&gt;7 to 30 days) Serious Adverse Event</description>
          <population>Safety Population (number of subjects with study catheter inserted)</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="348"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late Onset Serious Adverse Event (SAE)</title>
        <description>Occurrence of Late Onset (&gt;30 days) Serious Adverse Event</description>
        <time_frame>&gt;30 days up to 15 months</time_frame>
        <population>Safety Population (number of subjects with study catheter inserted) and excluding subjects who exited prior to 30 days of follow up in the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
          </group>
        </group_list>
        <measure>
          <title>Late Onset Serious Adverse Event (SAE)</title>
          <description>Occurrence of Late Onset (&gt;30 days) Serious Adverse Event</description>
          <population>Safety Population (number of subjects with study catheter inserted) and excluding subjects who exited prior to 30 days of follow up in the study.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="346"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>15 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group</title>
          <description>Pulmonary vein isolation (PVI) by RF ablation treatment with the THERMOCOOL SMARTTOUCH® SF catheter in persistent AF population.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="85" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Paralysis</sub_title>
                <description>Possibly device related and possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pulmonary Edema (Respiratory Insufficiency)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Major Vascular Access Complication / Bleeding</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial Fribrillation</sub_title>
                <description>Not Device Related and Not Procedure Related</description>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <description>Possibly device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <description>Possibly device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <description>Definitely procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <description>possibly procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diplopia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Esophageal Ulcer</sub_title>
                <description>Definitely device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Esophageal Ulcer</sub_title>
                <description>Definitely procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Intra-abdominal hematoma</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Intra-abdominal hematoma</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Esophageal stenosis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Esophageal stenosis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Complication associated with urinary catheter</sub_title>
                <description>Possibly procedure related, not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Complication associated with urinary catheter</sub_title>
                <description>Definitely procedure related, not device related</description>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sepsis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <description>Definitely procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Seroma</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Fluid overload</sub_title>
                <description>Definitely procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Fluid Overload</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back disorder</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Back disorder</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebrovascular Accident (CVA) / Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident (CVA) / Stroke</sub_title>
                <description>Not procedure or device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Major depression</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoxia</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <description>Possibly procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Squamous cell cercinoma</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Squamous cell cercinoma</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <description>Not device related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <description>Not procedure related</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="348"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kendra McInnis</name_or_title>
      <organization>Biosense Webster Inc</organization>
      <phone>+1 949 322-8010</phone>
      <email>kmcinnis@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

